Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART: Melatonin for Benzodiazepine Discontinuation in Schizophrenia
NCT01431092Phase 4Completed
- Start
- Oct 2011
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in benzodiazepine dependence. Started Oct 2011; status: completed.
02
Drugs
melatonin
03
Conditions
benzodiazepine dependence
Beyond the preview
Go deeper on NCT01431092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01431092.